Current Report Filing (8-k)
March 20 2020 - 2:10PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (date of earliest event reported): March 17, 2020
NGEN
TECHNOLOGIES HOLDINGS CORP.
(Exact
Name of Registrant as Specified in Its Charter)
Nevada
|
|
000-55177
|
|
27-4715504
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
5430
Lyndon B Johnson Fwy, Suite 1200, Dallas, TX
|
|
75240
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (845) 610-3817
Liberated
Solutions, Inc.
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (See General Instruction A.2 below):
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
None
|
|
N/A
|
|
N/A
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On
March 17, 2020, Dr. Steven Folkerth notified the Board of Directors of Ngen Technologies Holdings Corp. (the “Company”)
of his resignation, effective immediately, from his position as a director and as the Company’s Chief Medical Officer.
Also
on March 17, 2020, Jay Silverman notified the Company’s Board of Directors of his resignation, effective immediately, from
his position as a director.
Dr. Folkerth’s and
Mr. Silverman’s resignations are not as a result of any disagreement with the Company on any matter relating to the Company’s
operations, policies or practices. The Board intends to conduct a search for new directors to fill the Board vacancies created
by the resignations. Until such vacancies are filled, Ed Carter will continue as the Company’s sole director.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
Date:
March 20, 2020
|
NGEN TECHNOLOGIES HOLDINGS CORP.
|
|
|
|
|
By:
|
/s/
Ed Carter
|
|
|
Ed
Carter
|
|
|
Chief
Executive Officer
|